An isolated raised HE4 was observed in 6/15 (40%) malignancies, including lung (3/3), all of which were non-small cell lung cancers, renal (1/1), colorectal (1/4) and endometrial cancers (1/3). This evidence concerns the gene WFDC2 and non-small cell lung carcinoma.